Literature DB >> 28966336

Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.

Naoto Katakami1,2.   

Abstract

Diabetic macroangiopathy, atherosclerosis secondary to diabetes mellitus (DM), causes cerebro-cardiovascular diseases, which are major causes of death in patients with DM and significantly reduce their quality of life. The alterations in vascular homeostasis due to endothelial and vascular smooth muscle cell dysfunction are the main features of diabetic macroangiopathy. Although multiple metabolic abnormalities that characterize diabetes are involved in the progression of atherosclerosis in patients with DM, it may be said that prolonged exposure to hyperglycemia and insulin resistance clustering with other risk factors such as obesity, arterial hypertension, and dyslipidemia play crucial roles. Laboratory and clinical researches in the past decades have revealed that major biochemical pathways involved in the development of diabetic macroangiopathy are as follows: overproduction of reactive oxygen species, increased formation of advanced glycation end-products (AGEs) and activation of the AGEs-receptor for AGE axis, polyol and hexosamine flux, protein kinase C activation, and chronic vascular inflammation. Among them, oxidative stress is considered to be a key factor.

Entities:  

Keywords:  Advanced glycation end-products (AGEs); Atherosclerosis; Cardiovascular disease; Diabetes; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28966336      PMCID: PMC5770221          DOI: 10.5551/jat.RV17014

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  86 in total

1.  The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.

Authors:  T Higashi; H Sano; T Saishoji; K Ikeda; Y Jinnouchi; T Kanzaki; N Morisaki; H Rauvala; M Shichiri; S Horiuchi
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

2.  Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Science       Date:  2015-07-17       Impact factor: 47.728

3.  Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.

Authors:  Takashi Ashino; Masayuki Yamamoto; Takemi Yoshida; Satoshi Numazawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-14       Impact factor: 8.311

4.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

5.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

Review 6.  Nrf2-Keap1 defines a physiologically important stress response mechanism.

Authors:  Hozumi Motohashi; Masayuki Yamamoto
Journal:  Trends Mol Med       Date:  2004-11       Impact factor: 11.951

Review 7.  Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases.

Authors:  Xi-Lin Chen; Charles Kunsch
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

8.  Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.

Authors:  Anna Rubartelli; Michael T Lotze
Journal:  Trends Immunol       Date:  2007-09-12       Impact factor: 16.687

9.  Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.

Authors:  Saeko Osawa; Naoto Katakami; Akio Kuroda; Mitsuyoshi Takahara; Fumie Sakamoto; Dan Kawamori; Takaaki Matsuoka; Munehide Matsuhisa; Iichiro Shimomura
Journal:  J Atheroscler Thromb       Date:  2016-09-02       Impact factor: 4.928

10.  Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease.

Authors:  Mingzhan Xue; Qingwen Qian; Antonysunil Adaikalakoteswari; Naila Rabbani; Roya Babaei-Jadidi; Paul J Thornalley
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

View more
  104 in total

Review 1.  LXRα Phosphorylation in Cardiometabolic Disease: Insight From Mouse Models.

Authors:  Maud Voisin; Matthew C Gage; Natalia Becares; Elina Shrestha; Edward A Fisher; Ines Pineda-Torra; Michael J Garabedian
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

Review 2.  Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage.

Authors:  Dannia Colín-Castelán; Silvio Zaina
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

3.  Utilization of NaF-PET/CT in assessing global cardiovascular calcification using CHADS2 and CHADS2-VASc scoring systems in high risk individuals for cardiovascular disease.

Authors:  Karthik Gonuguntla; Chaitanya Rojulpote; Shivaraj Patil; Abhijit Bhattaru; Pranav Karambelkar; Kiranmayi Vuthaluru; William Y Raynor; Austin J Borja; Vincent Zhang; Thomas J Werner; Oke Gerke; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

4.  Genotyping of interleukins-18 promoters and their correlation with coronary artery stenosis in Saudi population.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Torki A Zughaibi; Shazi Shakil
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

5.  Activating transcription factor 3 is a potential target and a new biomarker for the prognosis of atherosclerosis.

Authors:  Weiwei Qin; Huiyu Yang; Gaizhen Liu; Rui Bai; Yunfei Bian; Zhiming Yang; Chuanshi Xiao
Journal:  Hum Cell       Date:  2020-09-21       Impact factor: 4.174

Review 6.  Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Authors:  Maura Knapp; Xin Tu; Rongxue Wu
Journal:  Acta Pharmacol Sin       Date:  2018-06-04       Impact factor: 6.150

7.  Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia.

Authors:  Yonas Akalu; Yitayeh Belsti
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-13       Impact factor: 3.168

8.  Impacts of Glycemic Control on Intracranial Plaque in Patients with Type 2 Diabetes Mellitus: A Vessel Wall MRI Study.

Authors:  S Jiao; J Huang; Y Chen; Y Song; T Gong; J Lu; T Guo; J Zhang; C Zhang; M Chen
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-03       Impact factor: 3.825

Review 9.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.

Authors:  Toshihito Otani; Kakuhiro Yamaguchi; Satoshi Nakao; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Cancer Chemother Pharmacol       Date:  2021-08-04       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.